Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Encouraging phase I results reported for Supratek's lead oncology product

Aug. 20, 2001

Onyx regains development rights for nonintravenous administration of ONYX-015

Aug. 20, 2001

Zeltia and Ortho Biotech announce licensing agreement for ET-743

Aug. 14, 2001

Strategy for systemic administration of Reolysin explored

Aug. 13, 2001

Merck & Co. reports novel farnesyltransferase inhibitor with excellent cell potency

Aug. 13, 2001

First nonpeptide somatotropin sst3 antagonists reported

Aug. 13, 2001

Urokinase inhibitors with antiangiogenic activity reported by Abbott

Aug. 10, 2001

Cyclin-dependent kinase inhibitors identified by Bristol-Myers Squibb

Aug. 9, 2001

BVdU reported to be useful for inhibiting the growth of hyperproliferative cells

Aug. 9, 2001

Ascorbic acid enhances arsenic trioxide potency in MM cells

Aug. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...